NM_058216.3(RAD51C):c.145+2_145+7delinsCTAAG AND Breast-ovarian cancer, familial, susceptibility to, 3

Germline classification:: Likely pathogenic (1 submission)
Last evaluated:: Jan 2, 2024
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV004020887.1

Allele description [Variation Report for NM_058216.3(RAD51C):c.145+2_145+7delinsCTAAG]

NM_058216.3(RAD51C):c.145+2_145+7delinsCTAAG

Genes:

LOC130061310:ATAC-STARR-seq lymphoblastoid active region 12491 [Gene]
RAD51C:RAD51 paralog C [Gene - OMIM - HGNC]

Variant type:

Indel

Cytogenetic location:

17q22

Genomic location:

Preferred name:

NM_058216.3(RAD51C):c.145+2_145+7delinsCTAAG

HGVS:

NC_000017.11:g.58692790_58692795delinsCTAAG
NG_023199.1:g.5189_5194delinsCTAAG
NG_047169.1:g.4285_4290delinsCTTAG
NM_002876.4:c.145+2_145+7delinsCTAAG
NM_058216.3:c.145+2_145+7delinsCTAAGMANE SELECT
LRG_314:g.5189_5194delinsCTAAG
NC_000017.10:g.56770151_56770156delinsCTAAG
NM_058216.2:c.145+2_145+7delinsCTAAG

Links:

dbSNP: rs878855177

NCBI 1000 Genomes Browser:

rs878855177

Molecular consequence:

NM_002876.4:c.145+2_145+7delinsCTAAG - splice donor variant - [Sequence Ontology: SO:0001575]
NM_058216.3:c.145+2_145+7delinsCTAAG - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:: Breast-ovarian cancer, familial, susceptibility to, 3
Synonyms:: RAD51C-Related Breast/Ovarian Cancer; Breast-ovarian cancer, familial 3
Identifiers:: MONDO: MONDO:0013253; MedGen: C3150659; Orphanet: 145; OMIM: 613399

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004930457	Myriad Genetics, Inc.	criteria provided, single submitter (Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))	Likely pathogenic (Jan 2, 2024)	unknown	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004930457

Myriad Genetics, Inc.

criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))

Likely pathogenic
(Jan 2, 2024)

unknown

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Myriad Genetics, Inc., SCV004930457.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant is considered likely pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine